D122108 - 4th Annual Hereditary Cancer Symposium for Health Care Providers

---

LIVE

Friday, April 16, 2021, 8:00 AM - Saturday, April 17, 2021, 12:00 PM, Online, Houston, TX


AMA PRA Category 1 Credits™ (9.75 hours), Non-Physician Attendance (9.75 hours), ANCC Contact Hour(s) (9.16 hours), Medical Ethics/Professional Responsibility (9.75 hours)

Symposium targeted to inter-professional healthcare providers in working with Clinical Cancer Genetics.

1. Implement guidelines to assess and screen high-risk patients in daily practice.
2. Recognize and document key features associated with potential hereditary cancer predisposition and adequately to refer at risk patients for cancer assessment.
3. Recognize and implement surgical interventions, screening protocols, and systemic therapies appropriate for specific hereditary cancer predisposition syndrome/genes.
4. Recognize impact of genetic testing results on the patient, psychosocially and medically for current and long-term management.
5. Identify a genetic counseling service delivery model that fits their clinical practice and implement a referral strategy.
6. Differentiate the utility of various genetic testing modalities commonly used related to oncology risk and care.

1. Recognize key features associated with potential hereditary cancers.
2. Identify how the interprofessional teams work to utilize various genetic testing modalities commonly used for oncology risk and care.
3. Nurses will be able to identify a genetic counseling service delivery model that fits their clinical practice and referral strategies.
4. Recognize how to integrating genetics evaluations into cancer survivorship care.
5. Apply the understanding of inheritance patterns to help patients understand which family might be at risk.
6. Identify the impact of genetic testing results on the patient and their family, both medically and psychosocially

 Virtual Conference opens at 8:15 am on Friday, April 16, 2021 and the conference will adjourn at 12:00 pm on Saturday, April 17, 2021.

You will receive instructions for the Virtual program via email 3-5 days prior to the conference.  The only requirement for the online training is that you must have a laptop/desktop computer, webcam and access to stable internet connection.

The Department of Continuing Professional Education reserves the right to cancel activities prior to the scheduled date if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, email or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of the Department of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee.
 
The Department of Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

The conference organizing committee wishes to express appreciation to Pfizer for their commitment to continuing medical education by providing an educational grant in support of this activity.

The conference organizing committee wishes to express appreciation to the following companies:

AstraZeneca Pharmaceuticals

Invitae

W9 Form Exhibit at this Event